CDH1 and neoplasm: TGF-β1 has been recognized to function as a tumor promoter by inducing EMT, which features the loss of epithelial phenotypes (e.g. E-cadherin) and the acquisition of mesenchymal phenotypes (e.g. N-cadherin and Vimentin) [23].